Crysvita Europese Unie - Nederlands - EMA (European Medicines Agency)

crysvita

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - geneesmiddelen voor de behandeling van botziekten - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Silodosin Recordati Europese Unie - Nederlands - EMA (European Medicines Agency)

silodosin recordati

recordati ireland ltd - silodosin - prostaathyperplasie - urologicals, alfa-adrenoreceptor antagonisten - de behandeling van de tekenen en symptomen van goedaardige prostaatvergroting (bph) bij volwassen mannen.

Leflunomid Sandoz 10 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

leflunomid sandoz 10 mg filmomh. tabl.

sandoz sa-nv - leflunomide 10 mg - filmomhulde tablet - 10 mg - leflunomide 10 mg - leflunomide

Leflunomid Sandoz 20 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

leflunomid sandoz 20 mg filmomh. tabl.

sandoz sa-nv - leflunomide 20 mg - filmomhulde tablet - 20 mg - leflunomide 20 mg - leflunomide

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Europese Unie - Nederlands - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaccins - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.

Dimethyl fumarate Neuraxpharm Europese Unie - Nederlands - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Camcevi Europese Unie - Nederlands - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - prostaatnoplasma - endocriene therapie - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Leflunomide AB 10 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

leflunomide ab 10 mg filmomh. tabl.

aurobindo sa-nv - leflunomide 10 mg - filmomhulde tablet - leflunomide

Leflunomide AB 10 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

leflunomide ab 10 mg filmomh. tabl.

aurobindo sa-nv - leflunomide 10 mg - filmomhulde tablet - leflunomide

Leflunomide AB 20 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

leflunomide ab 20 mg filmomh. tabl.

aurobindo sa-nv - leflunomide 20 mg - filmomhulde tablet - leflunomide